228 related articles for article (PubMed ID: 9011381)
41. [Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].
Fan J; Dong L; Chen Z; Bei D
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):46-50. PubMed ID: 24680408
[TBL] [Abstract][Full Text] [Related]
42. Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens.
Kanellopoulou M; Makri A; Damaskopoulou H; Malamou-Lada H
Clin Microbiol Infect; 2000 Dec; 6(12):653-6. PubMed ID: 11284924
[TBL] [Abstract][Full Text] [Related]
43. Relationship between differences in 16-, 14-, and 15-membered ring macrolides and Streptococcus pyogenes resistance.
Braga PC
Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):146-8. PubMed ID: 11939399
[No Abstract] [Full Text] [Related]
44. A regionwide intervention to promote appropriate antibiotic use in children reversed trends in erythromycin resistance to Streptococcus pyogenes.
Gagliotti C; Buttazzi R; Di Mario S; Morsillo F; Moro ML
Acta Paediatr; 2015 Sep; 104(9):e422-4. PubMed ID: 26058421
[No Abstract] [Full Text] [Related]
45. Group A streptococcal resistance to clindamycin and erythromycin.
Sorbello AF
JAMA; 1989 Sep; 262(10):1329. PubMed ID: 2668573
[No Abstract] [Full Text] [Related]
46. Erythromycin resistance in Finland declines after reduction in macrolide use.
Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
[No Abstract] [Full Text] [Related]
47. Study on carrier rate of Streptococcus pyogenes among the school children and antimicrobial susceptibility pattern of isolates.
Prajapati A; Rai SK; Mukhiya RK; Karki AB
Nepal Med Coll J; 2012 Sep; 14(3):169-71. PubMed ID: 24047008
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic resistance in group A streptococci.
Gerber MA
Pediatr Clin North Am; 1995 Jun; 42(3):539-51. PubMed ID: 7761140
[TBL] [Abstract][Full Text] [Related]
49. Trends in Streptococcus pyogenes resistance to erythromycin in Slovakia: is there a correlation with consumption?
Krcmery V; Foltan V; Langsadl L; Liskov A; Babela R
Scand J Infect Dis; 2002; 34(5):400. PubMed ID: 12069033
[No Abstract] [Full Text] [Related]
50. Continued Increase of Erythromycin Nonsusceptibility and Clindamycin Nonsusceptibility Among Invasive Group A Streptococci Driven by Genomic Clusters, United States, 2018-2019.
Li Y; Rivers J; Mathis S; Li Z; McGee L; Chochua S; Metcalf BJ; Fleming-Dutra KE; Nanduri SA; Beall B
Clin Infect Dis; 2023 Feb; 76(3):e1266-e1269. PubMed ID: 35684991
[TBL] [Abstract][Full Text] [Related]
51. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
[No Abstract] [Full Text] [Related]
52. Incidence of severe streptococcal-related diseases in Italian children in an era of high group A streptococcal resistance to macrolides. Italian Group A Streptococcal Resistance to Macrolides Study Group.
Principi N; Marchisio P
J Chemother; 1999 Oct; 11(5):379-84. PubMed ID: 10632384
[TBL] [Abstract][Full Text] [Related]
53. Leg ulcer infection with an erythromycin-resistant Streptococcus pyogenes.
Hardie R; Hardie RA
Scott Med J; 1986 Jan; 31(1):39. PubMed ID: 3515552
[No Abstract] [Full Text] [Related]
54. Erythromycin or Clindamycin - is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?
Leszczyński P; Sokół-Leszczyńska B; Pietrzak B; Sawicka-Grzelak A; Wielgoś M
Pol J Microbiol; 2017 Jul; 66(2):265-268. PubMed ID: 28735311
[TBL] [Abstract][Full Text] [Related]
55. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.
Stevens DL; Gibbons AE; Bergstrom R; Winn V
J Infect Dis; 1988 Jul; 158(1):23-8. PubMed ID: 3292661
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy of streptococcal infections: implications of antimicrobial drug resistance in Streptococcus pyogenes.
Hansman D
Med J Aust; 1989 Jun; 150(11):611-2. PubMed ID: 2657346
[No Abstract] [Full Text] [Related]
57. Streptococcus pyogenes: resistant, tolerant, neither or both?
Mortensen JE; McDowell T
Adv Exp Med Biol; 1995; 390():109-17. PubMed ID: 8718606
[No Abstract] [Full Text] [Related]
58. Therapeutic implications of erythromycin resistance in group A streptococci.
Coonan K; Kaplan EL
Pediatr Infect Dis J; 1993 Mar; 12(3):261-2. PubMed ID: 8451111
[No Abstract] [Full Text] [Related]
59. The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy.
Boccia D; Alegiani SS; Pantosti A; Moro ML; Traversa G
Eur J Clin Pharmacol; 2004 Apr; 60(2):115-9. PubMed ID: 15014920
[TBL] [Abstract][Full Text] [Related]
60. Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.
Lavergne V; Laverdière M; Duchesne A; Béliveau C; Delorme J; Di Zazzo A; Labbé AC
Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):532-4. PubMed ID: 16874484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
